Champlain Investment Partners’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.2M Sell
815,173
-213,674
-21% -$7.59M 0.33% 98
2025
Q4
$37M Buy
1,028,847
+41,248
+4% +$1.52M 0.38% 95
2025
Q3
$31.1M Sell
987,599
-9,692
-1% -$348K 0.23% 125
2025
Q2
$42.4M Buy
997,291
+383,498
+62% +$16M 0.3% 116
2025
Q1
$27.4M Sell
613,793
-9,647
-2% -$519K 0.2% 133
2024
Q4
$34.2M Buy
+623,440
New +$31.6M 0.22% 124

Other funds holding VCEL

Champlain Investment Partners's VCEL Position: Q1 2026 in Review

Champlain Investment Partners reduced its Vericel Corp (VCEL) stake by 21% in Q1 2026, selling an estimated $7.59M and leaving 815,173 shares worth $26.2M. The position accounts for 0.33% of the portfolio, ranked #98.

Champlain Investment Partners first reported a position in VCEL in Q4 2024 and has held it in 6 quarters since. The position peaked at $42.4M in Q2 2025. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Champlain Investment Partners held 815,173 shares of Vericel Corp worth $26.2M as of Q1 2026.
  • Champlain Investment Partners sold 213,674 Vericel Corp shares in Q1 2026, an estimated $7.59M.
  • Vericel Corp made up 0.33% of Champlain Investment Partners's portfolio in Q1 2026, its #98 holding.
  • Champlain Investment Partners first reported a position in Vericel Corp in Q4 2024 and has held it in 6 quarters since.
  • Champlain Investment Partners's Vericel Corp position peaked at $42.4M in Q2 2025.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Champlain Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.